Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities    
Net loss $ (256,540) $ (262,851)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Non-cash LNG inventory write-downs 0 17,826
Depreciation and amortization expense 92,101 47,557
Amortization of debt issuance costs and discount 14,176 7,546
Loss on early extinguishment of debt 53,526 96,273
Total losses on derivatives, net 48,555 13,040
Net cash used for settlement of derivative instruments (8,775) (40,796)
Other 136 92
Changes in restricted cash for certain operating activities 54,551 167,083
Changes in operating assets and liabilities:    
Accounts and other receivables (30,897) 238
Accounts receivable—affiliate (36,274) (48)
Advances to affiliate (398) (27,672)
Inventory (26,175) (24,080)
Accounts payable and accrued liabilities 107,047 558
Due to affiliates 9,217 (8,154)
Deferred revenue (2,960) (3,003)
Other, net (4,865) (6,754)
Other, net—affiliate 430 22,198
Net cash provided by (used in) operating activities 12,855 (947)
Cash flows from investing activities    
Property, plant and equipment, net (1,884,238) (2,130,959)
Use of restricted cash for the acquisition of property, plant and equipment 1,914,532 2,178,481
Other (38,319) (50,711)
Net cash used in investing activities (8,025) (3,189)
Cash flows from financing activities    
Proceeds from issuances of debt 5,418,500 2,250,000
Repayments of debt (3,130,000) 0
Debt issuance and deferred financing costs (89,433) (177,001)
Investment in restricted cash (2,263,075) (2,072,999)
Distributions to owners (74,268) (74,261)
Other (306) 0
Net cash used in financing activities (138,582) (74,261)
Net decrease in cash and cash equivalents (133,752) (78,397)
Cash and cash equivalents—beginning of period 146,221 248,830
Cash and cash equivalents—end of period $ 12,469 $ 170,433